| COVİD-19 MANAGEMENT IN SÜLEYMAN DEMİREL UNIVERSITY HOSPITAL: THE FIRST YEAR CHRONOLOGY OF A PANDEMIC | Rasih YAZKAN, Nihat ŞENGEZE, İsmail ZİHNİ, Mehmet ERDOĞAN, Nilgün ŞENOL, Osman ERGÜN, Erdoğan İBRİŞİM | 1–10 |
| The Effect of Covid-19 Pandemic on Urology Practice: A Two- Center Study | Sefa Alperen ÖZTÜRK, Ahmet GUZEL | 11–18 |
| Assessment of Anxiety and Stress Levels of Healthcare Professionals Working in Pandemic Service and Intensive Care | Emel YILDIZ, Sevil ALKAN ÇEVİKER, Murat Emre TOKUR, Özlem KOÇAK, Sıdıka BATAŞ BİLGEÇ, Ayşe YILDIRIMER, Canan BALCI | 19–29 |
| Covid-19 Vaccines | Onur KAYA | 31–35 |
| ANTICOAGULANT THERAPY IN COVID-19 | Demircan ÖZBALCI | 37–45 |
| COVID-19 and Rational Antibiotic Usage | Füsun Zeynep AKÇAM | 47–49 |
| Acute Respiratory Distress Syndrome Management in COVID-19 Patients | Pınar KARABACAK, Pakize KIRDEMİR | 51–56 |
| ABDOMINAL IMAGING IN COVID-19 INFECTION | Hüseyin AYDIN | 57–60 |
| HEMATOLOGICAL MANIFESTATIONS AND ANTICOAGULANT USE IN CHILDREN WITH COVID-19 DISEASE | Ebru YILMAZ | 61–66 |
| Effect of Corona Virus (COVID-19) in Kidney Transplant Recipients | Esma SELÇUK, Hanan ALSAMMARRAIE | 73–78 |
| COVID-19: Antiviral Therapy | Gülruhsar YILMAZ | 79–85 |
| Immune Plasma Applications in Covid-19 Treatment | Esra NURLU TEMEL | 87–92 |
| Pathophysıology of Covıd 19 Related Multisystem Inflammatory Syndrome in Children | Emine AKKUZU | 93–96 |
| CARDIOTORACIC RADIOLOGICAL IMAGING AND THE ROLE OF ARTIFICIAL INTELLIGENCE IN COVID-19 | Veysel Atilla AYYILDIZ | 101–112 |
| Evaluation of Maternal and Neonatal Outcomes in Pregnant Patients Complicated by COVID-19 İnfection | Ümran KILINÇDEMİR, Gökhan BAYHAN | 119–124 |
| OPERATING ROOM MANAGEMENT AND ANESTHETIC APPROACH IN COVID-19 PANDEMIC | Filiz ALKAYA SOLMAZ, Mustafa Soner ÖZCAN, Eyyüp Sabri ÖZDEN, Onur BALIK, Pakize KIRDEMİR | 125–131 |
| Antiviral Treatment in Pediatric COVID-19 Patients | Hakan SALMAN, Muhammet KÖŞKER | 133–135 |
| Microbiological Diagnosis of SARS-CoV-2 Infection | Mümtaz Cem ŞİRİN, Emel SESLİ ÇETİN, Buket ARIDOĞAN | 137–145 |
| Pediatric COVID-19 and Gastrointestinal System | Hakan SALMAN, Mustafa AKÇAM | 147–151 |
| TASTE AND SMELL DISORDERS IN COVID 19 PATIENTS | Hasan YASAN, Mehmet Emre SİVRİCE | 153–156 |
| Colchicine and Non-steroidal Anti-inflammatory Drug Applications in the Treatment of COVID-19 | Esra NURLU TEMEL | 157–162 |
| Anti-cytokine treatments in Covid-19 disease: IL-6 receptor inhibitor (Tocilizumab) and IL-1 receptor antagonist (Anakinra) | Atalay DOĞRU | 163–166 |
| COVID-19 and the Nervous System | Müjgan ARSLAN | 167–169 |
| COVID-19 and Diabetes Mellitus Management | Hakan KORKMAZ | 171–175 |
| Monitoring of COVID19 in pediatric intensive care unit | Nagehan ASLAN, Erhan BERK | 177–187 |
| COVID-19 MANAGEMENT IN EMERGENCY MEDİCİNE | Furkan Çağrı OĞUZLAR, Önder TOMRUK | 189–196 |
| CORTICOSTEROID TREATMENT OF COVID-19 PATIENTS: WHEN AND HOW? | Münire ÇAKIR, Mehtap ÇAKIR | 197–208 |
| Novel Coronavirus Disease from Pediatric Endocrinology Perspective | Müge ATAR | 209–213 |
| Oxygen therapy in COVID: to whom, when, how? | Önder ÖZTÜRK | 215–222 |
| Pulmonary Rehabilitation In the Patients with COVID-19 | Feray SOYUPEK | 223–228 |
| CARDIOVASCULAR EFFECTS OF COVID-19 PANDEMIA | Mustafa KARABACAK | 229–233 |
| COVID-19 and NEUROLOGICAL DISORDERS | Duygu AYDEMİR, Özge TÜRK, Burak CEYLAN, Neslişah YILDIRIM, Ekin BAYLAM, İsra Nur KOÇKAR, Gizem SARIOĞLU, Süleyman KUTLUHAN, Serpil DEMİRCİ, Yrd. Doç. Dr. Vedat YÜREKLİ, Hasan KOYUNCUOĞLU, Melike DOĞAN ÜNLÜ, Nihat ŞENGEZE | 235–240 |
| THE IMPORTANCE OF VACCINATION IN THE PANDEMIA AND COVID-19 VACCINATION STUDIES | Funda YILDIRIM BAŞ | 245–248 |
| The Big Outbreak Diseases History And The Covid-19 Pandemic | Fuat İNCE, Rasih YAZKAN | 249–251 |